These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7121561)

  • 1. Polymorphonuclear leukocyte chemotaxis in sporotrichosis.
    Hachisuka H; Tajiri S; Hongo K; Sasai Y
    Mycopathologia; 1982 Jul; 79(1):39-41. PubMed ID: 7121561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotaxis and random migration of polymorphonuclear leukocytes in ulcerative colitis examined by the agarose method.
    Hermanowicz A; Nawarska Z
    Scand J Gastroenterol; 1981; 16(8):961-6. PubMed ID: 7336136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of immunization and potassium iodide on polymorphonuclear leukocyte chemiluminescence in experimental murine sporotrichosis.
    Shimizu T; Hiruma M; Akiyama M; Kukita A; Tsuru S
    Mycoses; 1989 Sep; 32(9):443-7. PubMed ID: 2608091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis.
    Ternowitz T
    J Am Acad Dermatol; 1986 Dec; 15(6):1191-9. PubMed ID: 3027138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphonuclear leukocyte chemotaxis in dermatitis herpetiformis.
    Esca SA; Pehamberger H; Silny W; Holubar K
    Acta Derm Venereol; 1981; 61(1):61-3. PubMed ID: 6164218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous migration and chemotactic activity of neutrophil polymorphonuclear leukocytes in recurrent aphthous ulceration.
    Dagalis P; Bagg J; Walker DM
    Oral Surg Oral Med Oral Pathol; 1987 Sep; 64(3):298-301. PubMed ID: 3477746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation impact on chemotactic activity generation for polymorphonuclear leukocytes.
    Morin A; Arvier MM; Doutremepuich F; Vigneron C
    Thromb Res; 1990 Sep; 59(6):979-84. PubMed ID: 2264022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotaxis under agarose: dependence upon polymorphonuclear leukocyte density.
    Schaack TM; Persellin RH
    J Immunol Methods; 1981; 47(3):359-64. PubMed ID: 7037970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotaxis of blood monocytes and polymorphonuclear leukocytes from patients with diabetes mellitus].
    Chang HN
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1979 Dec; 12(4):136-9. PubMed ID: 397877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotactic function of polymorphonuclear leukocytes from patients with recurrent infections: partial correction by levamisole "in vitro".
    Stein AN; Díez RA; Sen L; Estévez ME
    Allergol Immunopathol (Madr); 1985; 13(2):127-34. PubMed ID: 4003229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis--enhancing properties of psoriatic serum.
    Ellis CN; Kang S; Grekin RC; Voorhees JJ; Silva J
    J Am Acad Dermatol; 1985 Sep; 13(3):437-43. PubMed ID: 4056118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotaxis of human polymorphonuclear neutrophils under agarose: morphologic changes associated with the chemotactic response.
    Nelson RD; Fiegel VD; Simmons RL
    J Immunol; 1976 Nov; 117(5 Pt 1):1676-83. PubMed ID: 1002995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphonuclear leukocyte chemotaxis in generalized pustular psoriasis.
    Zelickson BD; Pittelkow MR; Muller SA; Johnson CM
    Acta Derm Venereol; 1987; 67(4):326-30. PubMed ID: 2445152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-specific immunity in aging: deficiency of monocyte and polymorphonuclear cell-mediated functions.
    Antonaci S; Jirillo E; Ventura MT; Garofalo AR; Bonomo L
    Mech Ageing Dev; 1984 Mar; 24(3):367-75. PubMed ID: 6717097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of methods for assessing chemotaxis of monocytes and polymorphonuclear leukocytes isolated from patients with AIDS or AIDS-related conditions.
    Martin LS; Spira TJ; Orloff SL; Holman RC
    J Leukoc Biol; 1988 Nov; 44(5):361-6. PubMed ID: 2846727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The response of polymorphonuclear leukocytes to chemotactic stimulation for smokers and non-smokers.
    Kraal JH; Kenney EB
    J Periodontal Res; 1979 Sep; 14(5):383-9. PubMed ID: 161779
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of antimicrobial agents on chemotaxis of polymorphonuclear leukocytes.
    Sugita K; Nishimura T
    J Chemother; 1995 Apr; 7(2):118-25. PubMed ID: 7666117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotactic defect in Wegener's granulomatosis.
    Niinaka T; Okochi T; Watanabe Y; Takahashi Y; Yamamura Y
    J Med; 1977; 8(3-4):161-75. PubMed ID: 267711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo potentiation of polymorphonuclear leukocyte chemotaxis by clindamycin.
    Skoutelis AT; Lianou PE; Bassaris HP
    Infection; 1993; 21(5):321-3. PubMed ID: 8300250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokinetic and chemotactic factors in psoriasis scale extracts.
    Dahl MV; Lindroos WE; Nelson RD
    J Invest Dermatol; 1978 Dec; 71(6):402-6. PubMed ID: 722120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.